AM
TEVA icon

AGF Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

AGF Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,744
Closed -$384K – 731
2026
Q1 		$384K Sell
12,744
-5,925
-32% -$191K ﹤0.01% 608
2025
Q4 		$583K Hold
18,669
– – ﹤0.01% 592
2025
Q3 		$377K Buy
+18,669
New +$328K ﹤0.01% 617
2025
Q2 		– Sell
-10,316
Closed -$159K – 727
2025
Q1 		$159K Hold
10,316
– – ﹤0.01% 654
2024
Q4 		$227K Hold
10,316
– – ﹤0.01% 673
2024
Q3 		$186K Buy
+10,316
New +$181K ﹤0.01% 663
2024
Q1 		– Sell
-21,869
Closed -$228K – 767
2023
Q4 		$228K Buy
+21,869
New +$204K ﹤0.01% 700
2023
Q2 		– Sell
-26,937
Closed -$238K – 757
2023
Q1 		$238K Buy
26,937
+12,014
+81% +$119K ﹤0.01% 723
2022
Q4 		$136K Buy
+14,923
New +$130K ﹤0.01% 740

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

AGF Management's TEVA Position: Q2 2026 in Review

AGF Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 12,744 shares — an estimated $384K sold.

AGF Management first reported a position in TEVA in Q4 2022 and held it in 9 quarters. The position peaked at $583K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • AGF Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
  • AGF Management sold 12,744 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $384K.
  • AGF Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2022 and held it in 9 quarters.
  • AGF Management's Teva Pharmaceutical Industries Limited position peaked at $583K in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.